Results for the substance corifolitropin alfa

Corifollitropin alfa is a medication used in fertility treatments to stimulate the development of ovarian follicles in women undergoing assisted reproductive procedures, such as in vitro fertilization. It is a long-acting recombinant analog of follicle-stimulating hormone (FSH).

The medication is administered via subcutaneous injection, usually once per cycle, under the supervision of a specialist physician. Common side effects include headaches, nausea, abdominal discomfort, and injection site reactions.

Corifollitropin alfa is contraindicated in women with hormone-dependent tumors, primary ovarian failure, or hypersensitivity to the active substance. Its use requires careful monitoring to prevent ovarian hyperstimulation syndrome.

This medication is an effective option for controlled ovarian stimulation, helping to increase the chances of success in assisted reproductive procedures.